Melanóma: vizsgálatok itt: Kína
69 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleDabrafenib and/or Trametinib Rollover Study
- Where
- Beijing
- Életkor
- 18 év to 100 év
- People
- 100 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT03340506 · EU 2023-509318-13-00 - 2. fázisTaking peopleA Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Where
- Beijing, Chongqing, Guangzhou, Shanghai, Xinxiang
- Életkor
- 18 év and over
- People
- 254 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07492680 - 1/2. fázisNot yet taking people in KínaCombination Immunotherapy Targeting Melanoma
- Where
- Shenzhen
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT06739226 - 2. fázisTaking peopleDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- Where
- Beijing, Changsha, Chengdu, Dongguan, Henan, Hubei, Shanghai, Shenyang, Wuhan, Xi'an, Xinxiang, Xuzhou
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00 - 1/2. fázisTaking peopleA Study of BL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other Solid Tumors
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07841925 - 2. fázisTaking peopleHS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma（FASTIL-Mela02）
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 90
- Run by
- Hangzhou Huasai Biomedicine Co., Ltd.
See details and how to joinNCT07406724 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Chengdu, Guangzhou
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 1/2. fázisTaking peopleA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Where
- Baoding, Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Ganzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Linyi, Luoyang, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Taizhou, Tianjin, Wuhan, Xi’an, Xinxiang, Zhengzhou
- Életkor
- 18 év and over
- People
- 862 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05914116 - 1/2. fázisTaking peopleA Trial of LBL-024 Monotherapy or Combination With Toripalimab in Patients With Advanced Melanoma.
- Where
- Beijing, Changchun, Chengdu, Fuzhou, Guangzhou, Hangzhou, Jinan, Kunming, Nanjing, Nanning, Shanghai, Taiyuan, Tianjin, Wuhan, Xi'an
- Életkor
- 18 év and over
- People
- 280
- Run by
- Nanjing Leads Biolabs Co.,Ltd
See details and how to joinNCT07099430 - No phaseTaking people68Ga-SorB PET/CT Imaging in Patients With Solid Tumors
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 50
- Run by
- Peking University Third Hospital
See details and how to joinNCT07760012 - 1. fázisTaking peopleSafety and Efficacy of BA1302 in Patients With Advanced Solid Tumors
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 167
- Run by
- Shandong Boan Biotechnology Co., Ltd
See details and how to joinNCT06596915 - 1/2. fázisTaking peopleA Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Where
- Chongqing, Hangzhou, Tianjin, Wuhan
- Életkor
- 18 év and over
- People
- 1438 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07070232 · EU 2024-517261-16-00 - 2. fázisTaking peopleCryoablation Combined With Hepatic Arterial Infusion of Iparomlimab and Tuvonralimab (QL1706), Intravenous Dacarbazine, and Oral Lenvatinib in Patients With Liver Metastases From Malignant Melanoma: a Single-arm, Phase II, Prospective Trial
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 28
- Run by
- Sun Yat-sen University
See details and how to joinNCT07847359 - 2. fázisTaking peopleClinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 50
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT07848243 - 1. fázisTaking peopleA Study of DXC014 in Patients With Advanced Solid Tumors.
- Where
- Beijing, Changsha, Hangzhou, Nanchang, Qingdao
- Életkor
- 18 év and over
- People
- 150
- Run by
- Hangzhou DAC Biotechnology Co., Ltd.
See details and how to joinNCT07177937 - 1. fázisTaking peopleAu-TMP and Radiotherapy for Advanced Melanoma With Anti-PD-1 Therapy
- Where
- Chengdu
- Életkor
- 18 év and over
- People
- 6
- Run by
- West China Hospital
See details and how to joinNCT07562841 - 2. fázisTaking peopleSintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery
- Where
- Changchun
- Életkor
- 18 év and over
- People
- 220
- Run by
- The First Hospital of Jilin University
See details and how to joinNCT07400302 - 1. fázisTaking peopleA Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
- Where
- Beijing, Haerbin, Linyi, Shanghai
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT04913285 - 2. fázisTaking peopleA Phase II Trial of LM103 in Advanced Melanoma
- Where
- Beijing, Changchun, Chengdu, Fuzhou, Guangzhou, Hangzhou, Nanjing, Nanning, Shanghai, Tianjin, Wuhan, Xi'an, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 92
- Run by
- Suzhou BlueHorse Therapeutics Co., Ltd.
See details and how to joinNCT07310784 - 1/2. fázisTaking peoplePhase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma and Urinary Tract Tumors
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 500
- Run by
- Shanghai JMT-Bio Inc.
See details and how to joinNCT07280832 - 2. fázisTaking peopleTunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant Melanoma
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 37
- Run by
- Sun Yat-sen University
See details and how to joinNCT07750067 - 1/2. fázisTaking peopleA Clinical Study of T3011 in Subjects With Advanced Melanoma
- Where
- Beijing, Bengbu, Changchun, Chengdu, Fuzhou, Zhengzhou, Zhongshan
- Életkor
- 18 év and over
- People
- 42
- Run by
- Shanghai Pharmaceuticals Holding Co., Ltd
See details and how to joinNCT06214156 - 2. fázisTaking peopleA Study of GC101 TIL in Advanced Melanoma
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 98
- Run by
- Shanghai Juncell Therapeutics
See details and how to joinNCT06703398 - 2. fázisTaking peopleA Study of IBI363 in Subjects With Advanced Melanoma
- Where
- Beijing, Changchun, Changsha, Fuzhou, Jinan, Kunming, Nanchang, Nanjing, Taiyuan, Zhengzhou
- Életkor
- 18 év and over
- People
- 180
- Run by
- Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT06081920 - 1. fázisTaking peopleA Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
- Where
- Fuzhou, Hangzhou, Luoyang, Tianjin, Wenzhou, Wuhan, Xi'an
- Életkor
- 18 év to 70 év
- People
- 174
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT07518043